SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla reports 47% rise in Q3 consolidated net profit

28 Jan 2025 Evaluate

Cipla has reported results for third quarter ended December 31, 2024 (Q3FY25)

The company has reported 29.08% rise in net profit at Rs 1438.15 crore for Q3FY25 as compared to Rs 1114.14 crore for the same quarter in the previous year. Total income of the company increased by 13.39% at Rs 5159.57 crore for Q3FY25 as compared to Rs 4550.31 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 47.38% rise in its net profit at Rs 1574.59 crore for the quarter ended December 31, 2024 as compared to Rs 1068.41 crore for the same quarter in the previous year. Total income of the company increased by 7.46% at Rs 7294.58 crore for Q3FY25 as compared to Rs 6788.44 crore for the corresponding quarter previous year.

Cipla Share Price

1232.60 -5.70 (-0.46%)
20-Apr-2026 14:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.40
Dr. Reddys Lab 1235.00
Cipla 1232.60
Zydus Lifesciences 936.50
Lupin 2327.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×